Chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis exhibits an increased inflammatory signature that is reduced in early-stage chronic lymphocytic leukemia.

MLA

Blanco, Gonzalo, et al. “Chronic Lymphocytic Leukemia-like Monoclonal B-Cell Lymphocytosis Exhibits an Increased Inflammatory Signature That Is Reduced in Early-Stage Chronic Lymphocytic Leukemia.” Experimental Hematology, vol. 95, Mar. 2021, pp. 68–80. EBSCOhost, https://doi.org/10.1016/j.exphem.2020.12.007.

APA

Blanco, G., Puiggros, A., Sherry, B., Nonell, L., Calvo, X., Puigdecanet, E., Chiu, P. Y., Kieso, Y., Ferrer, G., Palacios, F., Arnal, M., Rodríguez-Rivera, M., Gimeno, E., Abella, E., Rai, K. R., Abrisqueta, P., Bosch, F., Calon, A., Ferrer, A., … Espinet, B. (2021). Chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis exhibits an increased inflammatory signature that is reduced in early-stage chronic lymphocytic leukemia. Experimental Hematology, 95, 68–80. https://doi.org/10.1016/j.exphem.2020.12.007

Chicago

Blanco, Gonzalo, Anna Puiggros, Barbara Sherry, Lara Nonell, Xavier Calvo, Eulàlia Puigdecanet, Pui Yan Chiu, et al. 2021. “Chronic Lymphocytic Leukemia-like Monoclonal B-Cell Lymphocytosis Exhibits an Increased Inflammatory Signature That Is Reduced in Early-Stage Chronic Lymphocytic Leukemia.” Experimental Hematology 95 (March): 68–80. doi:10.1016/j.exphem.2020.12.007.